Clinical Trials Browser

Not yet recruiting × Platinum-resistant Ovarian Cancer (PROC) × Gynecologic × Clear all

NCT07075250 2025-07-20

RIFOC003

Phase 4 Not yet recruiting

Platinum-resistant Ovarian Cancer (PROC)

NCT06600841 2024-09-19

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

Phase 2 Not yet recruiting

Platinum-resistant Ovarian Cancer (PROC)